Profile data is unavailable for this security.
About the company
Beijing Biostar Pharmaceuticals Co Ltd is a Chinea-based company principally engaged in the research, development, production and sales of innovative drugs. The Company's products and pipeline mainly include Utidelone Injection, Utidelone Capsule, Utidelone Nanoformulation, Utidelone Antibody Drug Conjugate (ADC), BG22, BG18 and BG44. The Company's products are principally used for the treatment of relapsed or metastatic breast cancer, neoadjuvant treatment of human epidermal growth factor receptor 2 (HER2)-breast cancer neoadjuvant, advanced non-small cell lung cancer (NSCLC), solid tumors, breast cancer brain metastasis, lung cancer brain metastasis and other brain tumor indications. The Company mainly conducts its businesses in the domestic market.
- Revenue in HKD (TTM)--
- Net income in HKD--
- Incorporated2002
- Employees147.00
- LocationBeijing Biostar Pharmaceuticals Co Ltd1202, Tower BYicheng Fortune Center,Beijing Economic-BEIJING ChinaCHN
- Websitehttps://www.biostar-pharm.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Uni-Bio Science Group Ltd | 589.59m | 91.35m | 680.72m | 504.00 | 7.48 | 1.78 | 5.95 | 1.15 | 0.0152 | 0.0152 | 0.0976 | 0.0641 | 1.13 | 3.62 | 9.18 | 1,210,657.00 | 17.51 | 6.21 | 22.17 | 8.56 | 82.19 | 80.72 | 15.49 | 4.96 | 3.22 | 59.39 | 0.22 | 1,633.58 | 14.08 | 21.43 | 16.79 | 102.04 | 32.65 | -- |
| Pak Fah Yeow International Ltd | 199.03m | 70.97m | 747.94m | 100.00 | 10.54 | 1.06 | 9.64 | 3.76 | 0.2277 | 0.2277 | 0.6386 | 2.26 | 0.2227 | 1.84 | 24.74 | 1,877,594.00 | 7.94 | 5.03 | 8.68 | 5.24 | 87.44 | 82.23 | 35.66 | 23.92 | 6.21 | 7.72 | 0.0068 | 94.02 | -8.64 | 9.89 | -25.14 | 16.88 | 16.37 | -8.84 |
| Modern Chinese Medicine Group Co Ltd | 228.68m | 21.46m | 835.20m | 190.00 | 32.43 | 1.27 | 24.01 | 3.65 | 0.0358 | 0.0358 | 0.3811 | 0.9152 | 0.392 | 5.89 | 7.49 | 1,203,582.00 | 3.68 | 14.83 | 3.93 | 17.56 | 24.57 | 38.44 | 9.38 | 17.92 | 7.80 | 21.30 | 0.0003 | 2.85 | -37.78 | -0.4333 | -80.18 | -26.87 | 112.81 | -- |
| Lee's Pharmaceutical Holdings Ltd | 1.44bn | 97.81m | 859.70m | 1.04k | 8.79 | 0.4424 | 4.27 | 0.5985 | 0.1661 | 0.1661 | 2.44 | 3.30 | 0.5181 | 2.64 | 9.17 | 1,405,524.00 | 2.32 | 13.85 | 2.99 | 18.24 | 53.10 | 59.37 | 4.48 | 35.22 | 0.7111 | 7.99 | 0.1179 | 2.97 | 32.95 | 2.81 | 457.55 | -5.81 | -10.46 | -4.28 |
| Meilleure Health Intrntnl Indu Grp Ltd | 38.10m | 39.17m | 968.96m | 49.00 | 24.69 | 0.7958 | -- | 25.43 | 0.0096 | 0.0096 | 0.0093 | 0.2978 | 0.0223 | 0.0363 | 0.9608 | 828,173.90 | 2.28 | 2.74 | 2.60 | 3.02 | 72.64 | 47.18 | 102.27 | 28.59 | 2.39 | -- | 0.2211 | 41.83 | -60.81 | -26.41 | -20.45 | -- | -1.03 | -- |
| Transcenta Holding Ltd | 10.64m | -301.23m | 1.06bn | 171.00 | -- | 1.31 | -- | 99.79 | -0.7435 | -0.7435 | 0.0262 | 1.80 | 0.0075 | 0.3793 | 0.4927 | 57,826.02 | -21.21 | -32.48 | -30.08 | -41.13 | 34.76 | 22.08 | -2,831.15 | -1,072.37 | 0.4387 | -408.75 | 0.2437 | -- | -79.09 | -23.91 | 37.24 | -- | -60.12 | -- |
| 3D Medicines Inc | 507.11m | -190.57m | 1.09bn | 183.00 | -- | 1.35 | -- | 2.16 | -0.7779 | -0.7779 | 2.07 | 3.14 | 0.3728 | 7.53 | 6.78 | 2,655,023.00 | -14.79 | -- | -21.47 | -- | 92.11 | -- | -39.68 | -- | 1.59 | -- | 0.205 | -- | -29.81 | -- | 65.19 | -- | -- | -- |
| Jilin Provnc Hnn Chnglng Bio-pharm CoLtd | 1.05bn | 206.93m | 1.15bn | 798.00 | 5.58 | 0.589 | 4.80 | 1.10 | 0.3694 | 0.3694 | 1.87 | 3.50 | 0.3698 | 2.30 | 3.34 | 1,407,136.00 | 7.30 | 7.46 | 10.54 | 10.45 | 78.95 | 77.80 | 19.74 | 20.45 | 1.42 | -- | 0.0422 | 44.00 | 4.71 | 6.41 | 24.32 | 4.95 | -8.31 | -- |
| Beijing Biostar Pharmaceuticals Co Ltd | -100.00bn | -100.00bn | 1.35bn | 147.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 7.85 | -- | 24.19 | -- | -- | -- |
| Dawnrays Pharmaceutical (Holdings) Ltd | 1.26bn | 199.57m | 1.77bn | 1.12k | 8.90 | 0.4748 | 6.00 | 1.41 | 0.1326 | 0.1326 | 0.8359 | 2.49 | 0.2809 | 2.47 | 7.96 | 1,064,304.00 | 4.36 | 10.98 | 5.07 | 13.75 | 45.76 | 55.52 | 15.53 | 32.76 | 4.21 | -- | 0.0028 | 31.01 | -7.89 | 2.22 | 73.29 | 17.20 | 17.13 | 2.69 |
| Cutia Therapeutics | 283.11m | -534.12m | 1.83bn | 298.00 | -- | 1.89 | -- | 6.47 | -1.70 | -1.70 | 0.901 | 2.67 | 0.1908 | 2.55 | 5.57 | 850,183.20 | -36.00 | -- | -44.42 | -- | 34.92 | -- | -188.66 | -- | 2.92 | -- | 0.2774 | -- | 103.17 | -- | 77.91 | -- | -- | -- |
| Zhaoke Ophthalmology Ltd | 39.99m | -314.76m | 1.90bn | 270.00 | -- | 0.9794 | -- | 47.41 | -0.5689 | -0.5689 | 0.0724 | 3.53 | 0.0159 | 1.38 | 9.25 | 136,014.20 | -12.50 | -38.02 | -14.65 | -41.79 | 49.28 | -- | -787.13 | -4,412.89 | 4.36 | -29.83 | 0.1373 | -- | 269.73 | -- | 38.32 | -- | 18.80 | -- |
Data as of Feb 13 2026. Currency figures normalised to Beijing Biostar Pharmaceuticals Co Ltd's reporting currency: Hong Kong Dollar HKD
0.03%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Bosera Asset Management Co., Ltd.as of 30 Jun 2025 | 66.80k | 0.03% |
| Harvest Fund Management Co., Ltd.as of 30 Jun 2025 | 1.00k | 0.00% |
Data from 30 Sep 2025 - 05 Feb 2026Source: FactSet Research Systems Inc.
